In addition, GEPIA database analysis showed that the mRNA expression levels of EZH2 were significantly higher in breast cancer tissues than normal breast tissues (Supplementary Fig. S3) and its expression level was significantly associated with the poorer prognosis of patients in breast cancer (Supplementary Fig. S4). Here, EZH2 is linked to breast cancer.